NIH-funded study reports advance in blood-based detection of ptau181, a biomarker of Alzheimer’s disease

The study, published in Nature Medicine, reports and the development of a blood test to detect Alzheimer's disease for those with dementia symptoms. The ptau181 biomarker, found in plasma, was seen to be helpful in differentiating those with Alzheimer's disease and frontotemporal lobar degeneration (FTLD) from healthy individuals. The advancement of a blood test allows for more accurate and loss costly diagnosis of Alzheimer's disease. The team of researchers at the University of California, San Francisco was led by Adam Boxer, M.D., Ph.D.

Click here to read more.